A multi-institutional phase II study of high-dose hypofractionated proton beam therapy (HF-PBT) for unresectable primary liver cancers: Long-term outcomes in patients (pts) with hepatocellular carcinoma (HCC).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Theodore S. Hong, Jennifer Yon-Li Wo, Edgar Ben-Josef, Erin McDonnell, Lorraine C. Drapek, Lawrence Scott Blaszkowsky, Eunice Lee Kwak, Jeffrey W. Clark, Lipika Goyal, David P. Ryan, Milind M. Javle, Ronald Arellano, John A. Wolfgang, John Thomas Mullen, Cristina Ferrone, Kenneth Tanabe, Thomas F. DeLaney, Christopher H. Crane, Andrew X. Zhu
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2590483598